Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
{{output}}
The most common indication for allogeneic hematopoietic cell transplant (alloHCT) is maintenance of remission after initial treatment for patients with acute myeloid leukemia (AML). Loss of remission, relapse, remains however the most frequent cause of alloHCT... ...
